PRS38 - COST-CONSEQUENCE ANALYSIS OF FLUTICASONE FUROATE/VILANTEROL FOR ASTHMA MANAGEMENT IN SPAIN: AN ANALYSIS BASED ON THE SALFORD LUNG STUDY IN ASTHMA | Publicación